Literature DB >> 3117743

Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: the need for a change of strategy: a radiotherapeutic viewpoint.

A B Karim1, J H Kralendonk, K H Njo, A H Tierie, A Hasman.   

Abstract

Since 1974 through 1984, 137 selected patients with loco-regionally advanced carcinoma of the larynx (T3T4 N0-N3) were treated primarily with quality controlled high dose megavoltage radiation therapy with salvage surgery in reserve. This policy of treatment has yielded 67% loco-regional control probability with primary radiotherapy and 85% with salvage surgery at 3 years. Fourteen patients (14/38) had moderate to severe complications after salvage surgery. The quality of life of the patients successfully treated by radiation therapy is obviously and unquestionably better. Primary radiotherapy with salvage surgery in reserve should be accepted as the strategy of choice in at least a selected group of patients with advanced laryngeal carcinoma.

Entities:  

Mesh:

Year:  1987        PMID: 3117743     DOI: 10.1016/0360-3016(87)90157-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer.

Authors:  M A List; P Mumby; D Haraf; A Siston; R Mick; E MacCracken; E Vokes
Journal:  Qual Life Res       Date:  1997-04       Impact factor: 4.147

2.  [Reasons for the terms "radiosurgery" and "Gamma Knife"].

Authors:  K Hamm; G Surber
Journal:  HNO       Date:  2017-09       Impact factor: 1.284

3.  High-dose radiotherapy alone for patients with T4-stage laryngeal cancer.

Authors:  A Mucha-Małecka; K Składowski
Journal:  Strahlenther Onkol       Date:  2013-07-05       Impact factor: 3.621

4.  [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].

Authors:  C Rübe; O Micke; G Grevers; R Rohloff; H Kaufmann; M Busch; N Willich
Journal:  Strahlenther Onkol       Date:  1997-02       Impact factor: 3.621

Review 5.  Assessing quality of life in head and neck cancer.

Authors:  C C Gotay; T D Moore
Journal:  Qual Life Res       Date:  1992-02       Impact factor: 4.147

6.  Tumor Volumes and Prognosis in Laryngeal Cancer.

Authors:  Mohamad R Issa; Stuart E Samuels; Emily Bellile; Firas L Shalabi; Avraham Eisbruch; Gregory Wolf
Journal:  Cancers (Basel)       Date:  2015-11-10       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.